Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Tablet Process Development and Validation and the application of QbD (3 day)

11 Dec 2012 - 13 Dec 2012 - County House, 221-241 Beckenham Road, Beckenham, BR3 4UF, Nr London



Bookmark and Share


This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their implications for process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be comprehensively reviewed. The hands-on workshop day will enable you to experience at first hand the impact of processing parameters on product quality.

By the end of the course, you will

·         Understand the relationship between the principles of QbD and tablet development and process validation in generic and new product development

·         Understand the relationship between material properties, formulation development and process development

·         Understand the processes commonly used to manufacture tablets and the factors which affect them. Recognise how to identify critical processing parameters, and how to incorporate into a process validation program

·         Understand the principles of PAT, how and where it can be most effectively deployed

·         Know the latest FDA thinking on Process Development including the three key steps of validation

·         Gain practical hands on experience of the impact of processing parameters on product quality on the small scale.

       Who should attend?
The  course  is designed  for people new  to Process Development,  and  those  requiring  a
refresher in the area.  It will also benefit Process Development experts wishing to extend
their understanding of why products processes can go wrong, and regulatory and quality
personnel who need to understand the development process better.  The course will include the latest FDA guidance on the development of generic products under QbD.

       Course outline:
Day 1: 
Morning - Product development 
• Principles of Quality by Design and the product development process 
• Linking material properties to formulation and processing behaviour 
• FDA Guidance on Process Validation 
Workshop session - Understanding Quality by Design 
  Afternoon -
Mixing, and dry granulation 
• Identifying potential Critical Process Parameters. 
• Unit processes 1 - Mixing and blending 
• Assessing blend uniformity. Sampling problems and practice 
Workshop session - blend assessment practical. Effect of material properties on    powder
 mixing behaviour 
Day 2: 
Morning - EFPIA Case study. Wet granulation 
• The new regulatory landscape. Q8, Q9 and Q10 and their impact on product and
process development. 
• EFPIA case study  -  what would a QbD regulatory submission look like? 
• Use of Process Matrices in process development 
• Developing wet granulation processes 
• Granulation endpoint control 
  Afternoon -
Drying, compression and film coating 
• Drying  -  techniques and process control 
• Compression  -  opportunities and threats! 
• Developing film coating processes 
• Round-up session 
 
Day 3: Practical 
• Blending 
• Granulation 
• Drying 
• Milling 
• Sieving 
• Compression 
• Granule and product characterisation 
 
NOTE 
Wherever possible participants should bring practical problems and examples which can
be reviewed on the course. The course will be highly participative and useful for people
with or without experience. Numbers are restricted to guarantee personal involvement.    

Ful  Course Speakers
Dr Michael Gamlen is Managing Director of Pharmaceutical Development Services Ltd, 
a pharmaceutical consultancy based in Nottingham (UK).
 

       Dr Dipankar Dey, PharmaTraining Ltd - Dipankar Dey recently joined PharmaTraining Ltd as Training Manager.

        Full Fee: 3 day course £1770.00 (+ VAT £354.00 if applicable, see notes on VAT)  

Discount of 10% applies for booking 8 weeks in advance. Discount of 10% applies for booking more than 1 delegate. Discount of 10% applies for booking more than 1 course.

Maximum discount received is 15%


Dr






Further information
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!